The frequency of persistent symptoms after acute COVID-19 among Iraqi patients

Background: Post–coronavirus disease 2019 (COVID-19) symptoms tend to persist in many survivors of COVID-19. Objectives: To find out the prevalence of persistent symptoms that continue to appear after the eradication of the COVID-19 infection among Iraqi survivors. We hypothesized that wearing a mas...

Full description

Bibliographic Details
Main Authors: Shwan O Amen, Banan Q Rasool, Salah H Yousif, Sara S Shakir, Bnar S Shekho
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Medical Journal of Babylon
Subjects:
Online Access:http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2021;volume=18;issue=3;spage=235;epage=240;aulast=Amen
_version_ 1818559232574750720
author Shwan O Amen
Banan Q Rasool
Salah H Yousif
Sara S Shakir
Bnar S Shekho
author_facet Shwan O Amen
Banan Q Rasool
Salah H Yousif
Sara S Shakir
Bnar S Shekho
author_sort Shwan O Amen
collection DOAJ
description Background: Post–coronavirus disease 2019 (COVID-19) symptoms tend to persist in many survivors of COVID-19. Objectives: To find out the prevalence of persistent symptoms that continue to appear after the eradication of the COVID-19 infection among Iraqi survivors. We hypothesized that wearing a mask during the COVID-19 pandemic may lead to a lesser viral load in an individual who gets infected, thereby leading to milder symptoms and manifestations. Materials and Methods: Overall, 70 consecutive Iraqi patients diagnosed with COVID-19 during the period from early August to late September 2020 were enrolled in the study, and on a mean of 31 days after recovery, they were assessed for persistent symptoms after the acute COVID-19 infection. Results: The mean age ± SD was 40.5 ± 16.1 years old. On a mean of 31 days post-COVID-19 recovery, 91.4% of all the patients had at least one persistent symptom. The most common persistent symptoms recorded were fatigue (42.9%), dyspnea (32.8%), and chest pain (25.7%). There was a statistically significant difference (P = 0.002) among patients with hypertension, among whom 45.5% had persistent palpitation. Among patients with ischemic heart disease, 25% had constant chest pain, and 37.5% complained of palpitation post-recovery. Patients who had used masks before infection (85.4%) were managed at home, and they did not require hospitalization. Overall, 45.7% of those dyspneic during the infection period were still complaining of exertional dyspnea post-recovery (P = 0.041). Conclusion: A large proportion of the Iraqi patients with COVID-19 infection had persistent symptoms after recovery. The use of a mask before infection showed mild symptoms during the acute phase, and hospitalization or oxygen therapy was not indicated for them.
first_indexed 2024-12-14T00:22:43Z
format Article
id doaj.art-2d3af0bbe0ec4d4dbd48f340a8ef7e2a
institution Directory Open Access Journal
issn 1812-156X
2312-6760
language English
last_indexed 2024-12-14T00:22:43Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj.art-2d3af0bbe0ec4d4dbd48f340a8ef7e2a2022-12-21T23:25:10ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602021-01-0118323524010.4103/MJBL.MJBL_25_21The frequency of persistent symptoms after acute COVID-19 among Iraqi patientsShwan O AmenBanan Q RasoolSalah H YousifSara S ShakirBnar S ShekhoBackground: Post–coronavirus disease 2019 (COVID-19) symptoms tend to persist in many survivors of COVID-19. Objectives: To find out the prevalence of persistent symptoms that continue to appear after the eradication of the COVID-19 infection among Iraqi survivors. We hypothesized that wearing a mask during the COVID-19 pandemic may lead to a lesser viral load in an individual who gets infected, thereby leading to milder symptoms and manifestations. Materials and Methods: Overall, 70 consecutive Iraqi patients diagnosed with COVID-19 during the period from early August to late September 2020 were enrolled in the study, and on a mean of 31 days after recovery, they were assessed for persistent symptoms after the acute COVID-19 infection. Results: The mean age ± SD was 40.5 ± 16.1 years old. On a mean of 31 days post-COVID-19 recovery, 91.4% of all the patients had at least one persistent symptom. The most common persistent symptoms recorded were fatigue (42.9%), dyspnea (32.8%), and chest pain (25.7%). There was a statistically significant difference (P = 0.002) among patients with hypertension, among whom 45.5% had persistent palpitation. Among patients with ischemic heart disease, 25% had constant chest pain, and 37.5% complained of palpitation post-recovery. Patients who had used masks before infection (85.4%) were managed at home, and they did not require hospitalization. Overall, 45.7% of those dyspneic during the infection period were still complaining of exertional dyspnea post-recovery (P = 0.041). Conclusion: A large proportion of the Iraqi patients with COVID-19 infection had persistent symptoms after recovery. The use of a mask before infection showed mild symptoms during the acute phase, and hospitalization or oxygen therapy was not indicated for them.http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2021;volume=18;issue=3;spage=235;epage=240;aulast=Amenlong-term covid-19persistent covid-19 symptomsars-cov-2
spellingShingle Shwan O Amen
Banan Q Rasool
Salah H Yousif
Sara S Shakir
Bnar S Shekho
The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
Medical Journal of Babylon
long-term covid-19
persistent covid-19 symptom
sars-cov-2
title The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
title_full The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
title_fullStr The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
title_full_unstemmed The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
title_short The frequency of persistent symptoms after acute COVID-19 among Iraqi patients
title_sort frequency of persistent symptoms after acute covid 19 among iraqi patients
topic long-term covid-19
persistent covid-19 symptom
sars-cov-2
url http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2021;volume=18;issue=3;spage=235;epage=240;aulast=Amen
work_keys_str_mv AT shwanoamen thefrequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT bananqrasool thefrequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT salahhyousif thefrequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT sarasshakir thefrequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT bnarsshekho thefrequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT shwanoamen frequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT bananqrasool frequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT salahhyousif frequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT sarasshakir frequencyofpersistentsymptomsafteracutecovid19amongiraqipatients
AT bnarsshekho frequencyofpersistentsymptomsafteracutecovid19amongiraqipatients